Zobrazeno 1 - 10
of 19
pro vyhledávání: ''
Publikováno v:
Value in Health
Objectives We applied principles for conducting economic evaluations of factorial trials to a trial-based economic evaluation of a cluster-randomized 2 × 2 × 2 factorial trial. We assessed the cost-effectiveness of atorvastatin, omega-3 fish oil, a
Autor:
Eric K. H. Chan, Elizabeth C. Hsia, John D. Reveille, Stephen Xu, L. Kim, Akgun Ince, Atul Deodhar, Kim Hung Lo, N Li, S. Peterson, Diane D. Harrison, Chenglong Han
Publikováno v:
Value in Health. 23:1281-1285
Evaluate the effect of intravenous golimumab on health-related quality of life (HRQoL) in patients with ankylosing spondylitis (AS) through week 28 of the phase III, multicenter, randomized, double-blind, placebo-controlled GO-ALIVE study.Adult patie
Publikováno v:
Value in Health. 21:1365-1372
Background Warfarin use for stroke prevention in atrial fibrillation (AF) patients with chronic kidney disease is debated. Apixaban was shown to be safer than warfarin, with superior reduction in the risk of stroke, systemic embolism, mortality, and
Autor:
Zobair M. Younossi, Marc Bourliere, Linda Henry, Christophe Hézode, T. Asselah, Philippe Mathurin, Victor de Ledinghen, Maria Stepanova, Patrice Cacoub
Publikováno v:
Value in Health. 21:1218-1225
In addition to high efficacy, new anti-hepatitis C virus (HCV) regimens improve patient-reported outcomes (PROs), which must be considered by policymakers in different countries when deciding upon treatment coverage.To assess PROs of French patients
Publikováno v:
Value in Health. 21:318-325
Background Phosphate binders are used to treat hyperphosphatemia among patients with chronic kidney disease (CKD). Objectives To conduct an economic evaluation comparing calcium-free binders sevelamer and lanthanum with calcium-based binders for pati
Autor:
David Wonderling, Dalia Dawoud, Rachel O’Mahony, Stephanie A. Amiel, Jill Cobb, Bernard Higgins
Publikováno v:
Value in Health. 21:176-184
Objective To assess the relative efficacy and safety of basal insulin regimens in adults with type 1 diabetes mellitus (T1DM). Methods A systematic review and Bayesian network meta-analysis (NMA) of randomized controlled trials comparing two or more
Publikováno v:
Value in Health, 21(2), 193-202. Elsevier Ltd.
Objectives To assess cost effectiveness of abatacept versus adalimumab, each administered with methotrexate, in treating patients with rheumatoid arthritis (RA) stratified according to baseline anticitrullinated protein antibody (ACPA) levels (marker
Autor:
Keith A. Betts, Yanjun Bao, Murali Sundaram, Kim A. Papp, Min Yang, James Signorovitch, John Jarvis
Publikováno v:
Value in Health. 21:1-8
To compare outcomes between adalimumab and etanercept in the treatment of moderate to severe plaque psoriasis.Study groups included patients randomized to adalimumab or placebo (REVEAL and CHAMPION trials) and those randomized to etanercept or placeb
Publikováno v:
Value in Health. 20:1279-1287
Objectives To assess the cost-effectiveness of basal insulin regimens for adults with type 1 diabetes mellitus in England. Methods A cost-utility analysis was conducted in accordance with the National Institute for Health and Care Excellence referenc
Publikováno v:
Value in Health. 20:1329-1335
Objectives To forecast lifetime outcomes and cost of lumacaftor/ivacaftor combination therapy in patients with cystic fibrosis (CF) with homozygous phe508del mutation from the US payer perspective. Methods A lifetime Markov model was developed from a